代谢组学在玫瑰痤疮研究中的应用进展

doi:10.35541/cjd.20220782

Abstract

Abstract: 【Abstract】 Rosacea is a common chronic inflammatory skin disease whose exact pathogenesis has not been fully elucidated. Metabolomics has been widely used in the field of life science to provide strong evidence for exploring the pathogenesis and biomarkers of diseases. In recent years, researchers have applied metabolomics to rosacea-related fields using sebum, tear, saliva, and serum samples. This review summarizes research progress on current metabolomics methods and the application of metabolomics in rosacea.

Key words: Rosacea, Metabolomics, Sebum, Fatty acids, Biomarkers

Pan Ruoxin, Gu Duoduo, Zhang Yue, Li Min, Tao Meng, Xu Yang. Metabolomics in rosacea[J]. Chinese Journal of Dermatology, 2024, 57(2): 178-181.doi:10.35541/cjd.20220782

References ［42］

［1］	Gether L, Overgaard LK, Egeberg A, et al. Incidence and prevalence of rosacea: a systematic review and meta⁃analysis［J］. Br J Dermatol, 2018,179（2）:282⁃289. doi: 10.1111/bjd.16481.
［2］	中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业委员会. 中国玫瑰痤疮诊疗指南（2021版）［J］. 中华皮肤科杂志, 2021,54（4）:279⁃288. doi: 10.35541/cjd.20201078.
［3］	宋晓婷, 刘擘, 陈玉迪, 等. 玫瑰痤疮的病理生理发病机制研究进展［J］. 中华皮肤科杂志, 2022,55（5）:446⁃449. doi: 10.35541/cjd.20200178.
［4］	刘乙萱, 姜沛彧, 刘韵祎, 等. 玫瑰痤疮神经源性炎症及肉毒毒素治疗相关机制的研究进展［J］. 中华皮肤科杂志, 2022,55（6）:552⁃554. doi: 10.35541/cjd.20200266.
［5］	Woo YR, Han YJ, Kim HS, et al. Updates on the risk of neuropsychiatric and gastrointestinal comorbidities in rosacea and its possible relationship with the gut⁃brain⁃skin axis［J］. Int J Mol Sci, 2020,21（22）:8427. doi: 10.3390/ijms21228427.
［6］	Haber R, El Gemayel M. Comorbidities in rosacea: a systematic review and update［J］. J Am Acad Dermatol, 2018,78（4）:786⁃792.e8. doi: 10.1016/j.jaad.2017.09.016.
［7］	Schmidt DR, Patel R, Kirsch DG, et al. Metabolomics in cancer research and emerging applications in clinical oncology［J］. CA Cancer J Clin, 2021,71（4）:333⁃358. doi: 10.3322/caac.21670.
［8］	Nicholson JK, Lindon JC, Holmes E. ′Metabonomics′: under⁃standing the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data［J］. Xenobiotica, 1999,29（11）:1181⁃1189. doi: 10.1080/004982599238047.
［9］	Wishart DS, Cheng LL, Copié V, et al. NMR and metabolomics⁃a roadmap for the future［J］. Metabolites, 2022,12（8）:678. doi: 10.3390/metabo12080678.
［10］	Kiseleva O, Kurbatov I, Ilgisonis E, et al. Defining blood plasma and serum metabolome by GC⁃MS［J］. Metabolites, 2021,12（1）:15. doi: 10.3390/metabo12010015.
［11］	Furlani IL, da Cruz Nunes E, Canuto G, et al. Liquid chromatography⁃mass spectrometry for clinical metabolomics: an overview［J］. Adv Exp Med Biol, 2021,1336:179⁃213. doi: 10. 1007/978⁃3⁃030⁃77252⁃9_10.
［12］	Gika HG, Wilson ID, Theodoridis GA. LC⁃MS⁃based holistic metabolic profiling. Problems, limitations, advantages, and future perspectives［J］. J Chromatogr B Analyt Technol Biomed Life Sci, 2014,966:1⁃6. doi: 10.1016/j.jchromb.2014.01.054.
［13］	Lopes AS, Cruz EC, Sussulini A, et al. Metabolomic strategies involving mass spectrometry combined with liquid and gas chromatography［J］. Adv Exp Med Biol, 2017,965:77⁃98. doi: 10.1007/978⁃3⁃319⁃47656⁃8_4.
［14］	Oliveira RV, Simionato A, Cass QB. Enantioselectivity effects in clinical metabolomics and lipidomics［J］. Molecules, 2021,26（17）:5231. doi: 10.3390/molecules26175231.
［15］	Sarvin B, Lagziel S, Sarvin N, et al. Fast and sensitive flow⁃injection mass spectrometry metabolomics by analyzing sample⁃specific ion distributions［J］. Nat Commun, 2020,11（1）:3186. doi: 10.1038/s41467⁃020⁃17026⁃6.
［16］	Calabrese V, Schmitz⁃Afonso I, Riah⁃Anglet W, et al. Direct introduction MALDI FTICR MS based on dried droplet deposition applied to non⁃targeted metabolomics on Pisum sativum root exudates［J］. Talanta, 2023,253:123901. doi: 10. 1016/j.talanta.2022.123901.
［17］	Jaber MA, Benabdelkamel H, Dahabiyeh LA, et al. The metabolomics approach revealed a distinctive metabolomics pattern associated with hyperthyroidism treatment［J］. Front Endocrinol （Lausanne）, 2022,13:1050201. doi: 10.3389/fendo. 2022.1050201.
［18］	Graça G, Cai Y, Lau CE, et al. Automated annotation of untargeted all⁃ion fragmentation LC⁃MS metabolomics data with MetaboAnnotatoR［J］. Anal Chem, 2022,94（8）:3446⁃3455. doi: 10.1021/acs.analchem.1c03032.
［19］	Chen L, Lu W, Wang L, et al. Metabolite discovery through global annotation of untargeted metabolomics data［J］. Nat Methods, 2021,18（11）:1377⁃1385. doi: 10.1038/s41592⁃021⁃01303⁃3.
［20］	Elpa DP, Chiu HY, Wu SP, et al. Skin metabolomics［J］. Trends Endocrinol Metab, 2021,32（2）:66⁃75. doi: 10.1016/j.tem.2020. 11.009.
［21］	Ní Raghallaigh S, Bender K, Lacey N, et al. The fatty acid profile of the skin surface lipid layer in papulopustular rosacea［J］. Br J Dermatol, 2012,166（2）:279⁃287. doi: 10.1111/j.1365⁃2133. 2011.10662.x.
［22］	Nazzaro⁃Porro M, Passi S, Boniforti L, et al. Effects of aging on fatty acids in skin surface lipids［J］. J Invest Dermatol, 1979,73（1）:112⁃117. doi: 10.1111/1523⁃1747.ep12532793.
［23］	Kitagawa Y, Hayakawa K, Oikawa D, et al. Repeated restraint stress modifies fatty acid and amino acid metabolism in the mouse skin［J］. J Vet Med Sci, 2022,84（4）:511⁃519. doi: 10. 1292/jvms.21⁃0602.
［24］	Shine WE, McCulley JP, Pandya AG. Minocycline effect on meibomian gland lipids in meibomianitis patients［J］. Exp Eye Res, 2003,76（4）:417⁃420. doi: 10.1016/s0014⁃4835（03）00005⁃8.
［25］	Shin HS, Zouboulis CC, Kim MK, et al. Minocycline suppresses lipogenesis via inhibition of p300 histone acetyltransferase activity in human SZ95 sebocytes［J］. J Eur Acad Dermatol Venereol, 2022,36（8）:1325⁃1333. doi: 10.1111/jdv.18079.
［26］	Li J, Wang B, Deng Y, et al. Epidemiological features of rosacea in Changsha, China: a population⁃based, cross⁃sectional study［J］. J Dermatol, 2020,47（5）:497⁃502. doi: 10.1111/1346⁃8138. 15301.
［27］	Vieira AC, An HJ, Ozcan S, et al. Glycomic analysis of tear and saliva in ocular rosacea patients: the search for a biomarker［J］. Ocul Surf, 2012,10（3）:184⁃192. doi: 10.1016/j.jtos.2012.04.003.
［28］	Ozcan S, An HJ, Vieira AC, et al. Characterization of novel O⁃glycans isolated from tear and saliva of ocular rosacea patients［J］. J Proteome Res, 2013,12（3）:1090⁃1100. doi: 10.1021/pr3008013.
［29］	Li Y, Guo L, Hao D, et al. Association between rosacea and cardiovascular diseases and related risk factors: a systematic review and meta⁃analysis［J］. Biomed Res Int, 2020,2020:7015249. doi: 10.1155/2020/7015249.
［30］	Chen Q, Shi X, Tang Y, et al. Association between rosacea and cardiometabolic disease: a systematic review and meta⁃analysis［J］. J Am Acad Dermatol, 2020,83（5）:1331⁃1340. doi: 10.1016/j.jaad.2020.04.113.
［31］	Liu T, Xiao W, Chen M, et al. Aberrant amino acid metabolism promotes neurovascular reactivity in rosacea［J］. JCI Insight, 2022,7（22）:e161870. doi: 10.1172/jci.insight.161870.
［32］	李健, 宋志强. 玫瑰痤疮面部潮红与红斑新认识［J］. 中华皮肤科杂志, 2021,54（4）:360⁃363. doi: 10.35541/cjd.20190920.
［33］	Tsai TY, Yen H, Huang YC. Serum homocysteine, folate and vitamin B（12） levels in patients with psoriasis: a systematic review and meta⁃analysis［J］. Br J Dermatol, 2019,180（2）:382⁃389. doi: 10.1111/bjd.17034.
［34］	Chen J, Zhuang T, Chen J, et al. Homocysteine induces melanocytes apoptosis via PERK⁃eIF2α⁃CHOP pathway in vitiligo［J］. Clin Sci （Lond）, 2020,134（10）:1127⁃1141. doi: 10. 1042/CS20200218.
［35］	Tsai TY, Hsieh TS, Yang TH, et al. The effects of isotretinoin therapy on serum homocysteine, folate and vitamin B（12） levels in patients with acne: a meta⁃analysis and meta⁃regression［J］. J Eur Acad Dermatol Venereol, 2020,34（1）:e32⁃e34. doi: 10. 1111/jdv.15886.
［36］	Marasca C, Donnarumma M, Annunziata MC, et al. Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience［J］. Clin Exp Dermatol, 2019,44（3）:e28⁃e29. doi: 10.1111/ced.13798.
［37］	Chung BY, Kim HO, Park CW, et al. Relationships of serum homocysteine, vitamin B（12）, and folic acid levels with papulopustular rosacea severity: a case⁃control study［J］. Biomed Res Int, 2022,2022:5479626. doi: 10.1155/2022/5479626.
［38］	Koklesova L, Mazurakova A, Samec M, et al. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person［J］. EPMA J, 2021,12（4）:477⁃505. doi: 10.1007/s13167⁃021⁃00263⁃0.
［39］	Elsherbiny NM, Sharma I, Kira D, et al. Homocysteine induces inflammation in retina and brain［J］. Biomolecules, 2020,10（3）:393. doi: 10.3390/biom10030393.
［40］	Egeberg A, Weinstock LB, Thyssen EP, et al. Rosacea and gastrointestinal disorders: a population⁃based cohort study［J］. Br J Dermatol, 2017,176（1）:100⁃106. doi: 10.1111/bjd.14930.
［41］	Sener S, Akbas A, Kilinc F, et al. Thiol/disulfide homeostasis as a marker of oxidative stress in rosacea: a controlled spectrophotometric study［J］. Cutan Ocul Toxicol, 2019,38（1）:55⁃58. doi: 10.1080/15569527.2018.1517124.
［42］	Demir Pektas S, Cinar N, Pektas G, et al. Thiol/disulfide homeostasis and its relationship with insulin resistance in patients with rosacea［J］. J Cosmet Dermatol, 2022,21（6）:2655⁃2661. doi: 10.1111/jocd.14477.

[1]	Chen Zhu, Dong Liping, Xiao Fengli, . Research progress in atopic diseases from the perspective of metabolomics [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220366-e20220366.
[2]	Enze LI Lu CHEN Chu-Qiao ZHANG Jiao qingqing JI Jiang. Correlations of gut microbiota and short-chain fatty acids with chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2024, 0(3): 20230310-e20230310.
[3]	Wei Ziyu, Yang Yong. Role of ion channels in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 174-177.
[4]	Liu Tingwei, Meng Xiaoqi, Gu Duoduo, Pan Ruoxin, Zhang Yue, Xu Yang. Advances in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 186-190.
[5]	Li Ji, Xie Hongfu. How to avoid misdiagnosis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 119-122.
[6]	Jiang Xian, Song Deyu. Insights into rosacea from the perspective of psychosomatic medicine [J]. Chinese Journal of Dermatology, 2024, 57(2): 123-126.
[7]	Na Jun, Li Ruoyu, Zhong Shaomin, Yang Li, Wu Yan. Diagnosis and treatment of rosacea in the real world: a survey on the current status [J]. Chinese Journal of Dermatology, 2024, 57(2): 127-133.
[8]	Ma Guangrong, Xie Hongfu, Liu Jiashuang, Zhou Zhonglian, Zou Songqi, Huang Yingxue, Li Ji. Small intestinal bacterial overgrowth in patients with rosacea: prevalence and clinical features [J]. Chinese Journal of Dermatology, 2024, 57(2): 134-140.
[9]	Zhang Yue, Tao Meng, Li Min, Jiang Peiyu, Liu Yunyi, Liu Yixuan, Pan Ruoxin, Xu Yang. Severity assessment criteria for rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 182-185.
[10]	Zhang Xiaodong, Wang Manya, Zhu Yingjie, Luo Tiande, Liu Xiaoming. Application of fluorescence staining in the detection of Demodex mites in the facial skin [J]. Chinese Journal of Dermatology, 2023, 56(8): 766-769.
[11]	Xu Xili, Li Dongning, Duan Han, Wang Fei. Analysis of plasma amino acid profiles in adolescents and adults with atopic dermatitis [J]. Chinese Journal of Dermatology, 2023, 56(8): 742-750.
[12]	Tao Meng, Li Min, Liu Yixuan, Liu Yunyi, Jiang Peiyu, Zhang Jiawen, Nan Yuqing, Xu Yang. Correlation between rosacea and neuropsychiatric diseases [J]. Chinese Journal of Dermatology, 2023, 56(7): 693-697.
[13]	Mi Shuhong, Yu Yanqin, Hao Jinqi, Li Wei, Zhang Yang, Jia Ximei, Huang Yuxian, Sun Huaiyu, Shi Jihai. Analysis of imaging characteristics of papulopustular rosacea by high-frequency ultrasound combined with color Doppler flow imaging [J]. Chinese Journal of Dermatology, 2023, 56(6): 540-544.
[14]	Li Jiaqi, Ye Feng, Ju Qiang. Symbiotic homeostasis of Staphylococcus epidermidis is associated with common skin disorders [J]. Chinese Journal of Dermatology, 2023, 56(5): 459-462.
[15]	Li Rong, Zhang Jiaan, Chen Kun. Photoelectric therapy for rosacea [J]. Chinese Journal of Dermatology, 2023, 56(5): 468-470.

Metabolomics in rosacea

PDF

Knowledge

Abstract

Cite this article

share this article

References ［42］

Related Articles 15

Metrics

Comments

Recommended 10